Core-Trinity

Description

Research Findings

Science

TriCore is a next-generation, multi-receptor peptide designed to address obesity and metabolic disorders by targeting the body’s core metabolic pathways. It uniquely combines the activity of three key hormone receptors—GLP-1, GIP, and glucagon—to deliver a coordinated, synergistic metabolic effect.

By activating the GLP-1 and GIP receptors, TriCore helps reduce appetite, increase satiety, and enhance insulin secretion, leading to improved blood sugar control. Simultaneously, activation of the glucagon receptor (GCG) increases energy expenditure and promotes fat metabolism. Together, these mechanisms address both sides of metabolic health: reducing caloric intake while increasing energy utilization.

This integrated, three-pathway approach positions TriCore™ as a differentiated and promising therapeutic candidate for obesity and related metabolic conditions.

Benefits to the Human Body

TriCore has demonstrated significant benefits for weight management and metabolic health. Clinical data show meaningful reductions in body fat and waist circumference, along with improvements in insulin sensitivity and glycemic control. These effects make TriCore particularly impactful for individuals with obesity, insulin resistance, or type 2 diabetes.

Beyond weight loss, TriCore may help reduce the risk of cardiovascular disease by improving key metabolic markers associated with heart health. Its ability to regulate hunger while simultaneously enhancing fat burning supports sustainable, long-term weight management and may help prevent complications associated with metabolic syndrome.